Statistics
Publications
11
Citations
2.7K
H-Index
11
Active since
1998
Kevin L. Lorick is an author at National Cancer Institute specializing in molecular biology, life sciences, and gene expression.
Publications per year
1998–2012
11
11
Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics
Yili Yang, Jirouta Kitagaki, Ren‐Ming Dai et al. · Cancer Research · 2007 · 445 citations
Medicine, Oncology, Pharmacology +14
Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity
Marika Häkli, Kevin L. Lorick, Allan M. Weissman et al. · FEBS Letters · 2004 · 61 citations · Full text
1–5 of 11